Cytosar-U

Active Ingredient(s): Cytarabine, ARA-C
FDA Approved: * December 30, 1998
Pharm Company: * SICOR PHARMS
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Cytosar-U Overview

Cytarabine, also known as cytosine arabinoside (ara-C), is a chemotherapy medication used to treat acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), chronic myelogenous leukemia (CML), and non-Hodgkin's lymphoma.[1] It is given by injection into a vein, under the skin, or into the cerebrospinal fluid.[1] There is a liposomal formulation for which there is tentative evidence of better outcomes in lymphoma involving the meninges.[1] ...

Read more Cytosar-U Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Cytarabine

Recent Cytosar-U Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Cytarabine, ARA-C
  • Injection: 100mg, 100mg/ml, 100mg/vial, 1g, 1gm/vial, 20mg/ml, 2g, 2gm/vial, 500mg, 500mg/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Cytarabine, ARA-C or a similar ingredient: (1 result)